NPC showed its competitive spirit in both pre-event fundraising efforts and during the team competition at the inaugural Office Madness event on March 2, 2018 at the Bavarian Aid Society in Altoona, PA, to benefit The Giorgio Children’s Foundation for NF1.
A trio of teams represented NPC at Office Madness, which featured a total of 26 teams (with 6 team members each) from local businesses competing in office-themed games. The games included: 5 O’clock Dash, Wastepaper Basketball, Office Golf, Clipboard Pong, Binder Clip Skee Ball, and Rubber Band Archery.
NPC teams combined to raise $2,971 toward the event fundraising total of over $25,000. And the best part is that 100% of those donation dollars for The Giorgio Children’s Foundation are used to fund highly focused medical research to help end NF1.
The company’s orange team, Crush NF1, captured the overall event team trophy, while the green team, Now Playing for a Cause, recorded the fastest time in the championship round office relay race.
(from left) Brad Houseknecht, Jamie Eichenlaub – team captain, Mike Horetsky, Ryan McNeely, Jeremy Knott, Mark Steele.
(Seated, from left) Krissa Weyant – team captain, Jenna Houseknecht, Tarran Richers; (standing, from left) Aubry Hoffman, Paul Lauer, Jimmy Carrieri.
(Seated, from left) Amber Donaldson, Larissa Crum, Abbey Wisor; (standing, from left) AJ Farkus, Mike Hileman – team captain, Josh Barnhart.
NPC sponsored the 2018 Office Madness championship round relay race, and is also a major corporate sponsor for the Giorgio Foundation’s annual “An Evening to End NF1” gala in Altoona every November.
“All in all, I’m extremely happy with everything,” said Timmy Cassidy, Office Madness event coordinator. “It was an incredible night for the Giorgio Foundation. We had 26 teams in our first year and already have two teams added for next year.”
The 2nd Annual Office Madness event will be held Friday, March 1, 2019, once again at the Bavarian in Altoona.
The Giorgio Children’s Foundation for NF1 is a non-profit organization created to fund research to find a cure for NF1, or Neurofibromatosis type 1, which is a rare genetic disorder characterized by the development of noncancerous tumors of nerves and skin (neurofibromas). NF1 is typically diagnosed in early childhood. NF1 disables the gene that normally controls tumor growth; the result can be hundreds — or even thousands — of painful and disfiguring tumors.